References
- Meyers, B. R., Kaplan, K., and Weinstein, L., (1969). Microbiological and pharmacological behaviour of 7-chlorolincomycin. Appl. Microbiol., 17, 653–657.1. Meyers, B. R., Kaplan, K., and Weinstein, L., (1969). Microbiological and pharmacological behaviour of 7-chlorolincomycin. Appl. Microbiol., 17, 653–657.
- Wagner, J. g., Novak, E., and Patel, N. C., et al., (1968). Absorption, excretion and half-life of clindamycin in normal adult males. Amer. J. med. Sci., 256, 25–37.2. Wagner, J. g., Novak, E., and Patel, N. C., et al., (1968). Absorption, excretion and half-life of clindamycin in normal adult males. Amer. J. med. Sci., 256, 25–37.
- De Haan, R. M., Bosch, W. D. V., and Metzler, C. M., (1972). Clindamycin serum concentrations after administrations of clindamycin palmitate with food. J. clin. Pharmac., 12, 205–211.3. De Haan, R. M., Bosch, W. D. V., and Metzler, C. M., (1972). Clindamycin serum concentrations after administrations of clindamycin palmitate with food. J. clin. Pharmac., 12, 205–211.
- McGehee, R. F. Jr., Smith, C. B., and Wilcox, G., et al., (1968). Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clindamycin. Amer. J. med. Sci., 256, 270–292.4. McGehee, R. F. Jr., Smith, C. B., and Wilcox, g., et al., (1968). Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clindamycin. Amer. J. med. Sci., 256, 270–292.
- Brodasky, T. F., Argoudelis, A. D., and Ebie, T. E., (1968). Characterization and thin-layer chromatographic quantification of the human metabolite of 7-deoxy-7(S)-chloro-lincomycin (U.21251F). J. Antibiotics, (Tokyo), 21, 327–333.5. Brodasky, T. F., Argoudelis, A. D., and Ebie, T. E., (1968). Characterization and thin-layer chromatographic quantification of the human metabolite of 7-deoxy-7(S)-chloro-lincomycin (U.21251F). J. Antibiotics, (Tokyo), 21, 327–333.
- De Haan, R. M., Schellenberg, D., and Vanden, Bosch W.D., et al., (1972). Clindamycin palmitate in healthy men: general tolerance and effect on stools. Curr. ther. Res., 14, 81–90.6. De Haan, R. M., Schellenberg, D., and Vanden, Bosch W.D., et al., (1972). Clindamycin palmitate in healthy men: general tolerance and effect on stools. Curr. ther. Res., 14, 81–90.
- Lwin, N., and Collipp, P. J., (1970). Absorption and tolerance of clindamycin-2-palmitate in infants below 6 months of age. Curr. ther. Res., 12, 648–657.7. Lwin, N., and Collipp, P. J., (1970). Absorption and tolerance of clindamycin-2-palmitate in infants below 6 months of age. Curr. ther. Res., 12, 648–657.
- De Haan, R. M., and Schellenberg, D., (1972). Clindamycin palmitate flavoured granules. Multidose tolerance, absorption and urinary excretion study in healthy children. J. clin. Pharmac., 12, 74–83.8. De Haan, R. M., and Schellenberg, D., (1972). Clindamycin palmitate flavoured granules. Multidose tolerance, absorption and urinary excretion study in healthy children. J. clin. Pharmac., 12, 74–83.
- Bongiorno, J. R., Alcasid, M. L., and Chiaramonte, L. T., (1971). Treatment of pneumonia in children with Cleocin palmitate. Curr. ther. Res., 13, 667–670.9. Bongiorno, J. R., Alcasid, M. L., and Chiaramonte, L. T., (1971). Treatment of pneumonia in children with Cleocin palmitate. Curr. ther. Res., 13, 667–670.
- Kosmidis, J. C., Corbett, V., Cole, A. J. L., et al. The treatment of paediatric infections with the lincomycins. ( In press).10. Kosmidis, J. C., Corbett, V., Cole, A. J. L., et al. The treatment of paediatric infections with the lincomycins. (In press).